Medina, Elsebeto V.

HRN: 29-17-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/22/2026
06/29/2026
IV
2.25g
Q6H
CAP-MR, PTB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: